Financials

  • Market Capitalization 7.26 M
  • Employee 23
  • Founded 2015
  • CEO N/A
  • Website www.boltbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00N8MY5V9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.31
Price to sales ratio
1.33

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4882
ASBP
Aspire Biopharma Holdings, Inc. - Common Stock
5.97 USD-0.67%+1.02%+18.45%+282.69%7.73 M USD
4887
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.09 USD-1.55%+4.95%+6.26%+485.06%7.44 M USD
4898
IMRN
Immuron Limited - American Depositary Shares
1.22 USD-0.81%+5.17%+5.17%-32.97%7.14 M USD
4899
PMCB
PharmaCyte Biotech, Inc. - Common Stock
0.66 USD-5.71%-10.81%-14.29%-39.45%7.09 M USD

Frequently asked questions about Bolt Biotherapeutics, Inc. - Common Stock

What is the Bolt Biotherapeutics, Inc. - Common Stock stock price today?

The current price of Bolt Biotherapeutics, Inc. - Common Stock (BOLT) is 3.7800000000000002. Over the past 24 hours, the stock has changed by 0.00%. Follow the BOLT chart for real-time price dynamics.

What is the stock ticker of Bolt Biotherapeutics, Inc. - Common Stock?

Bolt Biotherapeutics, Inc. - Common Stock trades under the ticker BOLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bolt Biotherapeutics, Inc. - Common Stock stock going up?

BOLT has changed by -8.25% over the last week, -20.25% over the last month, and -36.47% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Bolt Biotherapeutics, Inc. - Common Stock net income for the last quarter?

Bolt Biotherapeutics, Inc. - Common Stock reported net income of -7.24 M for the last quarter. The previous quarter showed -6.63 M, which means net income changed by -9.24%.

How many employees does Bolt Biotherapeutics, Inc. - Common Stock have?

As of the latest available data, Bolt Biotherapeutics, Inc. - Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.

What is Bolt Biotherapeutics, Inc. - Common Stock EBITDA?

Bolt Biotherapeutics, Inc. - Common Stock EBITDA is -7.4 M, and its EBITDA margin is -28.45 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bolt Biotherapeutics, Inc. - Common Stock stock?

You can buy Bolt Biotherapeutics, Inc. - Common Stock (BOLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bolt Biotherapeutics, Inc. - Common Stock stock?

Investing in Bolt Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BOLT chart and related analysis on metatrader.com as part of your research.

News